Literature DB >> 12606012

Expression of human aromatase (CYP19) in Escherichia coli by N-terminal replacement and induction of cold stress response.

Norio Kagawa1, Qianwen Cao, Kazutomi Kusano.   

Abstract

CYP19 (P450arom) catalyzes the aromatization reaction of C19 steroids leading to estrogens. While readily expressed in insect cells, the human P450arom has been a difficult P450 to express in Escherichia coli at useful levels. In the present study, we replaced the N-terminal sequence in human CYP19 with the corresponding sequences of other microsomal P450s (CYP2C11 and CYP17) that are efficiently expressed in E. coli. Although the N-terminal replacement alone was not sufficient for the expression, human P450arom was successfully expressed up to the level of 240nmol/l culture by the combination of the N-terminal replacement and the induction of cold stress response by 1 microg/ml chloramphenicol. Membrane fractions containing the expressed P450arom catalyzed aromatization of androstenedione with a specific activity of 4.9 nmol/min/nmol P450. Our results are important to provide large quantities of human P450arom as an active form for structure-function studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606012     DOI: 10.1016/s0039-128x(02)00168-x

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  8 in total

1.  Evolution of diterpene metabolism: Sitka spruce CYP720B4 catalyzes multiple oxidations in resin acid biosynthesis of conifer defense against insects.

Authors:  Björn Hamberger; Toshiyuki Ohnishi; Britta Hamberger; Armand Séguin; Jörg Bohlmann
Journal:  Plant Physiol       Date:  2011-10-12       Impact factor: 8.340

2.  The critical iron-oxygen intermediate in human aromatase.

Authors:  Stephanie L Gantt; Ilia G Denisov; Yelena V Grinkova; Stephen G Sligar
Journal:  Biochem Biophys Res Commun       Date:  2009-07-08       Impact factor: 3.575

3.  Aromatase is phosphorylated in situ at serine-118.

Authors:  Todd W Miller; Incheol Shin; Norio Kagawa; Dean B Evans; Michael R Waterman; Carlos L Arteaga
Journal:  J Steroid Biochem Mol Biol       Date:  2008-09-04       Impact factor: 4.292

4.  Kinetic solvent isotope effect in steady-state turnover by CYP19A1 suggests involvement of Compound 1 for both hydroxylation and aromatization steps.

Authors:  Yogan Khatri; Abhinav Luthra; Ruchia Duggal; Stephen G Sligar
Journal:  FEBS Lett       Date:  2014-07-02       Impact factor: 4.124

5.  A recombinant CYP11B1 dependent Escherichia coli biocatalyst for selective cortisol production and optimization towards a preparative scale.

Authors:  Lina Schiffer; Simone Anderko; Anna Hobler; Frank Hannemann; Norio Kagawa; Rita Bernhardt
Journal:  Microb Cell Fact       Date:  2015-02-25       Impact factor: 5.328

6.  Cell foundry with high product specificity and catalytic activity for 21-deoxycortisol biotransformation.

Authors:  Shuting Xiong; Ying Wang; Mingdong Yao; Hong Liu; Xiao Zhou; Wenhai Xiao; Yingjin Yuan
Journal:  Microb Cell Fact       Date:  2017-06-13       Impact factor: 5.328

7.  Variability in Loss of Multiple Enzyme Activities Due to the Human Genetic Variation P284T Located in the Flexible Hinge Region of NADPH Cytochrome P450 Oxidoreductase.

Authors:  Shaheena Parween; Maria Natalia Rojas Velazquez; Sameer S Udhane; Norio Kagawa; Amit V Pandey
Journal:  Front Pharmacol       Date:  2019-10-15       Impact factor: 5.810

8.  Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase.

Authors:  Sameer S Udhane; Shaheena Parween; Norio Kagawa; Amit V Pandey
Journal:  Front Pharmacol       Date:  2017-08-25       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.